In the realm of women’s health, discussions often tend to conflate aesthetic issues such as bad breath, weight gain, rashes, acne or vaginal odours with health issues. Josephine Ornago, OutspokenPR discusses the effects of “bikini medicine”.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, hails a review of the assessment system for digital health apps.
Data reveals that the plastics and rubber sector has invested a total of $3.1 billion on R&D, up from $2.6 billion in the previous year. The level of increased investment is double that of the US average over the same period.
This latest article shifts the focus to another key area that needs to climb up to the top of healthcare agendas: the mental health issues of women, especially when these are encountered in combination with, or worsened by, life circumstances.
Medical technology is one of the most innovative sectors in a time that is not exactly lacking in technological developments. Austria occupies an internationally recognised position in this field.
In this second article devoted to analysing issues that need to be brought to the forefront of public awareness to support the femtech market, Josephine Ornago, owner at OutspokenPR, addresses the issue of pain in women’s health issues.
In the fast-paced world of medical technology, the demand for reliable and high-quality power solutions and advanced display technologies has never been greater.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications hails the issuing of the latest version of the new model for assessing value based procurement.
Josephine Ornago, owner at OutspokenPR, creates a four-part series to raise awareness for the femtech market. This series starts with the critical issue of the destigmatisation of the female reproductive apparatus in its entirety.
Following the fund’s first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing.
